These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27177192)

  • 1. The fermentation product 2,3-butanediol alters P. aeruginosa clearance, cytokine response and the lung microbiome.
    Nguyen M; Sharma A; Wu W; Gomi R; Sung B; Hospodsky D; Angenent LT; Worgall S
    ISME J; 2016 Dec; 10(12):2978-2983. PubMed ID: 27177192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolite transfer with the fermentation product 2,3-butanediol enhances virulence by Pseudomonas aeruginosa.
    Venkataraman A; Rosenbaum MA; Werner JJ; Winans SC; Angenent LT
    ISME J; 2014 Jun; 8(6):1210-20. PubMed ID: 24401856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice.
    Sandri A; Ortombina A; Boschi F; Cremonini E; Boaretti M; Sorio C; Melotti P; Bergamini G; Lleo M
    Virulence; 2018; 9(1):1008-1018. PubMed ID: 29938577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis.
    Yu H; Nasr SZ; Deretic V
    Infect Immun; 2000 Apr; 68(4):2142-7. PubMed ID: 10722612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS; Egan M; Kazmierczak BI
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung.
    O'Brien S; Fothergill JL
    FEMS Microbiol Lett; 2017 Aug; 364(15):. PubMed ID: 28859314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fermentation products in the cystic fibrosis airways induce aggregation and dormancy-associated expression profiles in a CF clinical isolate of Pseudomonas aeruginosa.
    Phan J; Gallagher T; Oliver A; England WE; Whiteson K
    FEMS Microbiol Lett; 2018 May; 365(10):. PubMed ID: 29617986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge.
    Yu H; Hanes M; Chrisp CE; Boucher JC; Deretic V
    Infect Immun; 1998 Jan; 66(1):280-8. PubMed ID: 9423869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microenvironmental characteristics and physiology of biofilms in chronic infections of CF patients are strongly affected by the host immune response.
    Jensen PØ; Kolpen M; Kragh KN; Kühl M
    APMIS; 2017 Apr; 125(4):276-288. PubMed ID: 28407427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early IL-2 treatment of mice with Pseudomonas aeruginosa pneumonia induced PMN-dominating response and reduced lung pathology.
    Calum HP; Moser C; Jensen PO; Bjarnsholt T; Givskov M; Høiby N
    APMIS; 2020 Dec; 128(12):647-653. PubMed ID: 32794206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reemergence of Lower-Airway Microbiota in Lung Transplant Patients with Cystic Fibrosis.
    Syed SA; Whelan FJ; Waddell B; Rabin HR; Parkins MD; Surette MG
    Ann Am Thorac Soc; 2016 Dec; 13(12):2132-2142. PubMed ID: 27925791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence.
    Bragonzi A; Paroni M; Nonis A; Cramer N; Montanari S; Rejman J; Di Serio C; Döring G; Tümmler B
    Am J Respir Crit Care Med; 2009 Jul; 180(2):138-45. PubMed ID: 19423715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biofilm-Induced Type 2 Innate Immunity in a Cystic Fibrosis Model of
    Bielen K; 's Jongers B; Boddaert J; Raju TK; Lammens C; Malhotra-Kumar S; Jorens PG; Goossens H; Kumar-Singh S
    Front Cell Infect Microbiol; 2017; 7():274. PubMed ID: 28680858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa Proteome under Hypoxic Stress Conditions Mimicking the Cystic Fibrosis Lung.
    Kamath KS; Krisp C; Chick J; Pascovici D; Gygi SP; Molloy MP
    J Proteome Res; 2017 Oct; 16(10):3917-3928. PubMed ID: 28832155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IL-1β in experimental cystic fibrosis upon P. aeruginosa infection.
    Palomo J; Marchiol T; Piotet J; Fauconnier L; Robinet M; Reverchon F; Le Bert M; Togbe D; Buijs-Offerman R; Stolarczyk M; Quesniaux VF; Scholte BJ; Ryffel B
    PLoS One; 2014; 9(12):e114884. PubMed ID: 25500839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,3-Butanediol catabolism in Pseudomonas aeruginosa PAO1.
    Liu Q; Liu Y; Kang Z; Xiao D; Gao C; Xu P; Ma C
    Environ Microbiol; 2018 Nov; 20(11):3927-3940. PubMed ID: 30058099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17β-Estradiol Dysregulates Innate Immune Responses to Pseudomonas aeruginosa Respiratory Infection and Is Modulated by Estrogen Receptor Antagonism.
    Abid S; Xie S; Bose M; Shaul PW; Terada LS; Brody SL; Thomas PJ; Katzenellenbogen JA; Kim SH; Greenberg DE; Jain R
    Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
    Klepac-Ceraj V; Lemon KP; Martin TR; Allgaier M; Kembel SW; Knapp AA; Lory S; Brodie EL; Lynch SV; Bohannan BJ; Green JL; Maurer BA; Kolter R
    Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
    Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.
    Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK
    Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.